Table 3 Mean changes in lipid levels in psoriasis patients and non-psoriasis subjects from 5 years before to 5 years after psoriasis incidence/index date based on random effects models
From: Trends in lipid profiles in patients with psoriasis: a population-based analysis
Lipid measure | Five-year change before the psoriasis incidence/index date | Five-year change after the psoriasis incidence/index date | ||
|---|---|---|---|---|
| Â | Psoriasis | Non-psoriasis | Psoriasis | Non-psoriasis |
Total Cholesterol (TC) | −6.2 (−11.7, -0.7)* | −15.3 (−20.7, -9.9) | −15.9 (−20.3, -11.4) | −13.6 (−17.8, -9.5) |
Low-density Lipoprotein | −8.3 (−13.0, -3.6) | −14.2 (−19.2, -9.2) | −13.2 (−17.1, -9.2) | −13.2 (−16.8, -9.5) |
High-density Lipoprotein (HDL) | 2.1 (0.8, 3.4) | 1.2 (−0.1, 2.6) | 1.4 (0.2, 2.5) | 1.7 (0.6, 2.9) |
Triglycerides | 1.6 (−13.5, 16.6) | −7.0 (−18.0, 4.0) | −20.2 (−31.3, -9.0) | −15.8 (−24.5, -7.2) |
TC: HDL ratio | −0.3 (−0.4, -0.1) | −0.4 (−0.6, -0.2) | −0.5 (−0.7, -0.4) | −0.5 (−0.6, -0.3) |